---
title: "Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292818385.md"
description: "Autonomix Medical secured $2.6 million via a warrant inducement, reducing Series C exercise prices to $6.00. The company issued new Series D-1 and D-2 warrants for 428,731 shares each at a $5.75 price with a 5.5-year term. Proceeds aim to raise capital and enhance liquidity. A 7% fee was paid to Maxim Group, and a resale registration will be filed."
datetime: "2026-07-15T21:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292818385.md)
  - [en](https://longbridge.com/en/news/292818385.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292818385.md)
---

# Autonomix Medical Secures $2.6 Million From Warrant Inducement, Issues New Series D Warrants

Autonomix Medical entered into a warrant inducement letter to prompt the exercise of existing Series C warrants and raise cash. The company reduced the exercise price of 428,731 existing warrants to $6.00, expecting approximately $2.6 million in gross proceeds, and issued new Series D-1 and D-2 warrants for 428,731 shares each at a $5.75 exercise price with a 5.5-year term. The new warrants are immediately exercisable, include standard ownership limits, and may be exercised cashlessly under certain registration conditions. Autonomix will file a resale registration for the new warrant shares and pay a 7% solicitation fee to Maxim Group.

**Agreement details:**

-   **Agreement type**: Warrant inducement letter for exercise of existing warrants and issuance of new warrants
-   **Counterparty**: Existing Warrant Holder
-   **Signed / Effective**: Jul 13 2026 / same
-   **Duration / Termination**: 5.5-year exercise term for New Warrants
-   **Reason**: Raise capital and enhance liquidity

Original SEC Filing: Autonomix Medical, Inc. \[ AMIX \] - 8-K - Jul. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)

## Related News & Research

- [Autonomix Medical secures new US patent for autonomic nervous system assessment technology](https://longbridge.com/en/news/293607812.md)
- [NV Gold issues warrants exercisable at $0.6 in $868,072 private placement](https://longbridge.com/en/news/293797425.md)
- [Boost Run sets USD 0.01 per warrant redemption, Aug. 20 exercise deadline](https://longbridge.com/en/news/293920690.md)
- [NanoViricides prices offering with 2,516,339 warrants at US$ 1.75 exercise price](https://longbridge.com/en/news/293753309.md)
- [Hertz public warrant exercise price falls to 12.81 after anti-dilution adjustment](https://longbridge.com/en/news/293660883.md)